Susquehanna International Group, LLP Intercept Pharmaceuticals, Inc. Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

24 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 14, 2023	SELL	$9.99 - $18.71 $459,540 - $860,660	-46,000 Reduced 21.4%	169,000 $3.13 Million
Q2 2023 Aug 11, 2023	SELL	$9.17 - $19.29 $188,902 - $397,374	-20,600 Reduced 8.74%	215,000 $2.38 Million
Q1 2023 May 16, 2023	SELL	$12.53 - $21.71 $972,328 - $1.68 Million	-77,600 Reduced 24.78%	235,600 $3.16 Million
Q4 2022 Feb 14, 2023	SELL	$11.61 - $16.11 $3.21 Million - $4.45 Million	-276,500 Reduced 46.89%	313,200 $3.87 Million
Q3 2022 Nov 14, 2022	SELL	$12.21 - $19.7 $1.8 Million - $2.9 Million	-147,200 Reduced 19.98%	589,700 $8.23 Million
Q2 2022 Aug 15, 2022	BUY	$11.23 - $19.59 $5.18 Million - $9.04 Million	461,600 Added 167.67%	736,900 $10.2 Million
Q1 2022 May 16, 2022	BUY	$13.37 - $17.79 $540,148 - $718,716	40,400 Added 17.2%	275,300 $4.48 Million
Q4 2021 Feb 14, 2022	BUY	$14.28 - $19.53 $1.8 Million - $2.46 Million	126,000 Added 115.7%	234,900 $3.83 Million
Q2 2021 Aug 11, 2021	BUY	$15.46 - $24.5 $231,900 - $367,500	15,000 Added 15.97%	108,900 $2.18 Million
Q1 2021 May 17, 2021	SELL	$19.33 - $37.75 $1.58 Million - $3.09 Million	-81,900 Reduced 46.59%	93,900 $2.17 Million
Q4 2020 Feb 16, 2021	BUY	$24.48 - $42.47 $1.55 Million - $2.68 Million	63,200 Added 56.13%	175,800 $4.34 Million
Q3 2020 Nov 16, 2020	BUY	$39.09 - $53.44 $1.52 Million - $2.08 Million	39,000 Added 52.99%	112,600 $4.67 Million
Q2 2020 Aug 14, 2020	SELL	$46.7 - $92.04 $2.12 Million - $4.19 Million	-45,500 Reduced 38.2%	73,600 $3.53 Million
Q1 2020 May 15, 2020	SELL	$48.35 - $118.68 $10.9 Million - $26.8 Million	-226,200 Reduced 65.51%	119,100 $7.5 Million
Q4 2019 Feb 14, 2020	BUY	$57.36 - $124.1 $3.72 Million - $8.04 Million	64,800 Added 23.1%	345,300 $42.8 Million
Q3 2019 Nov 14, 2019	SELL	$58.69 - $80.46 $4.01 Million - $5.5 Million	-68,400 Reduced 19.6%	280,500 $18.6 Million
Q2 2019 Aug 14, 2019	SELL	$77.77 - $120.68 $28.6 Million - $44.3 Million	-367,300 Reduced 51.28%	348,900 $27.8 Million
Q1 2019 May 15, 2019	BUY	$91.83 - $120.68 $28.1 Million - $36.9 Million	305,800 Added 74.51%	716,200 $80.1 Million
Q4 2018 Feb 14, 2019	BUY	$85.79 - $126.46 $3.54 Million - $5.22 Million	41,300 Added 11.19%	410,400 $41.4 Million
Q3 2018 Nov 14, 2018	BUY	$88.49 - $127.55 $6.36 Million - $9.17 Million	71,900 Added 24.19%	369,100 $46.6 Million
Q2 2018 Aug 14, 2018	BUY	$60.0 - $85.67 $588,000 - $839,566	9,800 Added 3.41%	297,200 $24.9 Million
Q1 2018 May 15, 2018	SELL	$52.72 - $67.25 $8.52 Million - $10.9 Million	-161,600 Reduced 35.99%	287,400 $17.7 Million
Q4 2017 Feb 14, 2018	SELL	$58.2 - $72.76 $18.7 Million - $23.4 Million	-321,800 Reduced 41.75%	449,000 $26.2 Million
Q3 2017 Nov 14, 2017	BUY	$57.01 - $118.75 $43.9 Million - $91.5 Million	770,800	770,800 $44.7 Million

Others Institutions Holding ICPT

# of Institutions

Shares Held

1.04M

Call Options Held

30K

Put Options Held

5.9K

View Full List

About INTERCEPT PHARMACEUTICALS, INC.

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

More about ICPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account